Established in 2022 between ISCT Asia Regional Executive Committee and ISCT Industry Leadership to support the rapid growth of the CGT market in the Asia Pacific Region.
APAC IC addresses challenges and bottlenecks impacting CGT development unique to the region, while promoting communication and alignment between Eastern and Western perspectives.
William (Bill) Milligan, BSc
Steminent BiotherapeuticsTaiwan/Canada
Antonio S. J. Lee, BSc.(Hons), MSc., Ph.D
Medipost Co., Ltd.South Korea & USA
Herman BohnenkampMiltenyi BiotecGermanyBingrong ChenThermo Fisher ScientificSingaporeVorapin ChinchalongpornESPThailandBryan ChoiEx Officio - ISCT Asia Regional CommitteeSouth KoreaLynn CsontosSTEMCELL TechnologiesCanadaAlannah EvansKite PharmaAustraliaPawan GuptaStempeutics Research Pvt. Ltd.IndiaJuliana GutierrezbioMérieuxJapanWilliam YK HwangNational Cancer Center, SingHealthSingaporeParesh JainBD BiosciencesSingaporeShin KawamataCyto-FactoJapanSrinivasan KellathurRocheSingaporeWenyan LeongTerumo Blood and Cell TechnologiesJapanMichael MayCCRMCanadaChris McClainNMDPUnited StatesJanet McPhersonCytivaAustraliaJohn NgDark Horse Consulting GroupSingapore
Gabrielle O'SullivanRoyal Prince Alfred HospitalAustraliaSteve OhIndependent Cell Therapy ConsultantSingaporeKarolis RosickasRegeneus Ltd.SingaporeGayatri SharmaCellvec Pte LtdSingaporeAnit SinghGenophore ResearchIndiaMitchell SivilottiOmniaBioUnited StatesNathan SmithCell Therapies Pty LtdAustraliaKunihiko SuzukiMEDINET Co LTD.JapanDan SwansoncGMPnowUnited StatesEddie TanSingaporeJake TreesGalapagosNetherlandsYoshi TsurumakiFIRM (Forum for Innovative Regenerative Medicine)JapanFranziska UberPL BioScienceGermanyZlatibor VelickovicRoyal Perth HospitalAustraliaBin WuAzentaSwitzerlandPeiqing ZhangCytivaSingapore
View All Committees